Warthin's tumor surgery: Difference between revisions
Jump to navigation
Jump to search
Nazia Fuad (talk | contribs) No edit summary |
Nazia Fuad (talk | contribs) |
||
| Line 8: | Line 8: | ||
* Surgery is the mainstay of treatment for Warthin's tumor. Recurrence is rare, occurring in 6 - 12% of cases. Warthin's tumor is highly unlikely to become [[malignant]]. | * Surgery is the mainstay of treatment for Warthin's tumor. Recurrence is rare, occurring in 6 - 12% of cases. Warthin's tumor is highly unlikely to become [[malignant]]. | ||
* [[Surgery]] should be followed by careful observation to watch for changes in the tumor over time.<ref name="pmid12593546">{{cite journal| author=Gooden E, Witterick IJ, Hacker D, Rosen IB, Freeman JL| title=Parotid gland tumours in 255 consecutive patients: Mount Sinai Hospital's quality assurance review. | journal=J Otolaryngol | year= 2002 | volume= 31 | issue= 6 | pages= 351-4 | pmid=12593546 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12593546 }} </ref> Frey syndrome has been successfully treated with injections of botulinum toxin A.<ref>Salivary gland tumor. Cancer.gov (2016). http://www.cancer.gov/types/head-and-neck/hp/salivary-gland-treatment-pdq Accessed on January 4, 2016</ref> | * [[Surgery]] should be followed by careful observation to watch for changes in the tumor over time.<ref name="pmid12593546">{{cite journal| author=Gooden E, Witterick IJ, Hacker D, Rosen IB, Freeman JL| title=Parotid gland tumours in 255 consecutive patients: Mount Sinai Hospital's quality assurance review. | journal=J Otolaryngol | year= 2002 | volume= 31 | issue= 6 | pages= 351-4 | pmid=12593546 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12593546 }} </ref> Frey syndrome has been successfully treated with injections of botulinum toxin A.<ref>Salivary gland tumor. Cancer.gov (2016). http://www.cancer.gov/types/head-and-neck/hp/salivary-gland-treatment-pdq Accessed on January 4, 2016</ref> | ||
'''Complications of surgery:''' | '''Complications of surgery:''' | ||
* Frey syndrome:<ref name="de Breevan der Waal2007">{{cite journal|last1=de Bree|first1=Remco|last2=van der Waal|first2=Isaäc|last3=Leemans|first3=C. René|title=Management of frey syndrome|journal=Head & Neck|volume=29|issue=8|year=2007|pages=773–778|issn=10433074|doi=10.1002/hed.20568}}</ref> | |||
** Frey syndrome is also known is [[gustatory]] sweating or [[auriculotemporal]] syndrome. | |||
** Include [[flushing]] and sweating over the [[parotid]] region during [[mastication]]. | |||
** May occur from 2 weeks to 2 years | |||
** Result from [[regeneration]] of cut [[parasympathetic]] fibres between [[otic ganglion]] and salivery tissue. | |||
** [[Botulinum toxin|Botulinum toxin A]] by intracutaneous injections provides successful treatment. | |||
* Bleeding and [[hematoma]] | |||
* [[Numbness]] in the distribution of great Auricular nerve including ear, face and neck | |||
* Sialocele and salivary [[fistula]] occurs in 5% post operative patients. | |||
* Deep lobe and [[pharyngeal]] space [[dissection]] may result in [[cramping]] and [[spasm]] in [[parotid]] region during [[swallowing]]. | |||
* Incidence of [[facial paralysis]] is 27-43% | |||
==References== | ==References== | ||
Revision as of 18:13, 6 December 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
|
Warthin's tumor Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Warthin's tumor surgery On the Web |
|
American Roentgen Ray Society Images of Warthin's tumor surgery |
|
Risk calculators and risk factors for Warthin's tumor surgery |
Overview
Surgery is the mainstay of treatment for Warthin's tumor.
Surgery
- Surgery is the mainstay of treatment for Warthin's tumor. Recurrence is rare, occurring in 6 - 12% of cases. Warthin's tumor is highly unlikely to become malignant.
- Surgery should be followed by careful observation to watch for changes in the tumor over time.[1] Frey syndrome has been successfully treated with injections of botulinum toxin A.[2]
Complications of surgery:
- Frey syndrome:[3]
- Frey syndrome is also known is gustatory sweating or auriculotemporal syndrome.
- Include flushing and sweating over the parotid region during mastication.
- May occur from 2 weeks to 2 years
- Result from regeneration of cut parasympathetic fibres between otic ganglion and salivery tissue.
- Botulinum toxin A by intracutaneous injections provides successful treatment.
- Bleeding and hematoma
- Numbness in the distribution of great Auricular nerve including ear, face and neck
- Sialocele and salivary fistula occurs in 5% post operative patients.
- Deep lobe and pharyngeal space dissection may result in cramping and spasm in parotid region during swallowing.
- Incidence of facial paralysis is 27-43%
References
- ↑ Gooden E, Witterick IJ, Hacker D, Rosen IB, Freeman JL (2002). "Parotid gland tumours in 255 consecutive patients: Mount Sinai Hospital's quality assurance review". J Otolaryngol. 31 (6): 351–4. PMID 12593546.
- ↑ Salivary gland tumor. Cancer.gov (2016). http://www.cancer.gov/types/head-and-neck/hp/salivary-gland-treatment-pdq Accessed on January 4, 2016
- ↑ de Bree, Remco; van der Waal, Isaäc; Leemans, C. René (2007). "Management of frey syndrome". Head & Neck. 29 (8): 773–778. doi:10.1002/hed.20568. ISSN 1043-3074.